A detailed history of Citigroup Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 72,064 shares of AGIO stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,064
Previous 24,317 196.35%
Holding current value
$2.41 Million
Previous $1.05 Million 205.44%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$41.19 - $49.72 $1.97 Million - $2.37 Million
47,747 Added 196.35%
72,064 $3.2 Million
Q2 2024

Aug 12, 2024

SELL
$27.55 - $48.83 $4.69 Million - $8.31 Million
-170,163 Reduced 87.5%
24,317 $1.05 Million
Q1 2024

May 10, 2024

BUY
$21.32 - $34.81 $1.86 Million - $3.04 Million
87,252 Added 81.37%
194,480 $5.69 Million
Q4 2023

Feb 09, 2024

BUY
$19.97 - $24.53 $843,472 - $1.04 Million
42,237 Added 64.99%
107,228 $2.39 Million
Q3 2023

Nov 09, 2023

SELL
$24.36 - $28.18 $13,105 - $15,160
-538 Reduced 0.82%
64,991 $1.61 Million
Q2 2023

Aug 10, 2023

SELL
$21.38 - $29.19 $2.6 Million - $3.55 Million
-121,741 Reduced 65.01%
65,529 $1.86 Million
Q1 2023

May 11, 2023

BUY
$21.74 - $30.93 $2.02 Million - $2.88 Million
93,111 Added 98.89%
187,270 $4.3 Million
Q4 2022

Feb 09, 2023

SELL
$24.81 - $31.52 $837,610 - $1.06 Million
-33,761 Reduced 26.39%
94,159 $2.64 Million
Q3 2022

Nov 10, 2022

SELL
$19.51 - $34.14 $190,495 - $333,342
-9,764 Reduced 7.09%
127,920 $3.62 Million
Q2 2022

Aug 10, 2022

BUY
$17.06 - $31.42 $1.8 Million - $3.32 Million
105,624 Added 329.46%
137,684 $3.05 Million
Q1 2022

May 12, 2022

SELL
$26.68 - $34.81 $3.23 Million - $4.21 Million
-120,994 Reduced 79.05%
32,060 $934,000
Q4 2021

Feb 10, 2022

BUY
$29.58 - $49.78 $2.9 Million - $4.88 Million
98,113 Added 178.58%
153,054 $5.03 Million
Q3 2021

Nov 10, 2021

BUY
$41.92 - $58.18 $2.3 Million - $3.2 Million
54,941 New
54,941 $2.54 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.83B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.